One Johnson & Johnson Plaza
New Brunswick, NJ 08933
United States
732 524 0400
https://www.jnj.com
Setor(es): Healthcare
Indústria: Drug Manufacturers - General
Funcionários Integrais: 131.900
Nome | Título | Pagar | Exercido | Nascido em |
---|---|---|---|---|
Mr. Joaquin Duato | CEO & Chairman | 30,98M | 74,83M | 1963 |
Mr. Joseph J. Wolk CPA | Executive VP & CFO | 15,85M | N/A | 1967 |
Dr. Peter M. Fasolo Ph.D. | Executive VP & Chief Human Resources Officer | 10,73M | N/A | 1963 |
Ms. Jennifer L. Taubert | Executive VP & Worldwide Chairman of Innovative Medicine | 15,5M | N/A | 1964 |
Dr. John C. Reed M.D., Ph.D. | Executive Vice President of Innovative Medicine, R&D | 42,81M | N/A | 1958 |
Mr. Robert J. Decker Jr. | Controller & Chief Accounting Officer | N/A | N/A | 1972 |
Mr. James Swanson | Executive VP & Chief Information Officer | N/A | N/A | 1966 |
Ms. Jessica Moore | Vice President of Investor Relations | N/A | N/A | N/A |
Mr. Dirk Brinckman | Chief Compliance Officer | N/A | N/A | N/A |
Ms. Elizabeth Forminard | Executive VP & General Counsel | N/A | N/A | 1971 |
O QualityScore de governança da ISS da Johnson & Johnson a partir de 1 de março de 2024 é 2. As principais pontuações para Auditoria são: 6; Conselho: 4; Direitos de Acionistas: 2; Compensação: 3.